Abstract:Homozygous mutations in the progranulin gene (GRN) are associated with neuronal ceroid lipofuscinosis 11 (CLN11), a rare lysosomal-storage disorder characterized by cerebellar ataxia, seizures, retinitis pigmentosa, and cognitive disorders, usually beginning between 13 and 25 years of age. This is a rare condition, previously reported in only four families. In contrast, heterozygous GRN mutations are a major cause of frontotemporal dementia associated with neuronal cytoplasmic TDP-43 inclusions. We identified homozygous GRN mutations in six new patients. The phenotypic spectrum is much broader than previously reported, with two remarkably distinct presentations, depending on the age of onset. A childhood/juvenile form is characterized by classical CLN11 symptoms at an early age at onset. Unexpectedly, other homozygous patients presented a distinct delayed phenotype of frontotemporal dementia and parkinsonism after 50 years; none had epilepsy or cerebellar ataxia. Another major finding of this study is that all GRN mutations may not have the same impact on progranulin protein synthesis. A hypomorphic effect of some mutations is supported by the presence of residual levels of plasma progranulin and low levels of normal transcript detected in one case with a homozygous splice-site mutation and late onset frontotemporal dementia. This is a new critical finding that must be considered in therapeutic trials based on replacement strategies. The first neuropathological study in a homozygous carrier provides new insights into the pathological mechanisms of the disease. Hallmarks of neuronal ceroid lipofuscinosis were present. The absence of TDP-43 cytoplasmic inclusions markedly differs from observations of heterozygous mutations, suggesting a pathological shift between lysosomal and TDP-43 pathologies depending on the mono or bi-allelic status. An intriguing observation was the loss of normal TDP-43 staining in the nucleus of some neurons, which could be the first stage of the TDP-43 pathological process preceding the formation of typical cytoplasmic inclusions. Finally, this study has important implications for genetic counselling and molecular diagnosis. Semi-dominant inheritance of GRN mutations implies that specific genetic counseling should be delivered to children and parents of CLN11 patients, as they are heterozygous carriers with a high risk of developing dementia. More broadly, this study illustrates the fact that genetic variants can lead to different phenotypes according to their mono- or bi-allelic state, which is a challenge for genetic diagnosis.

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

An Alternative In Vitro Model Of Neurodegeneration In Ftld-U With Pgrn Mutation

Elevated Progranulin Contributes to Synaptic and Learning Deficit Due to Loss of Fragile X Mental Retardation Protein.

Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.

Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg

Progranulin mutations as risk factors for Alzheimer disease

Exaggerated Inflammation, Impaired Host Defense, and Neuropathology in Progranulin-Deficient Mice

Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis

Frontotemporal Dementia Patient Neurons With Progranulin Deficiency Display Protein Dyshomeostasis

Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation

Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia

FTLD-TDP with and Without GRN Mutations Cause Different Patterns of CA1 Pathology

Homozygous GRN mutations: unexpected phenotypes and new insights into pathological and molecular mechanisms

Progranulin as a therapeutic target in neurodegenerative diseases

Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation

Ftd-Psp Is An Unusual Clinical Phenotype In A Frontotemporal Dementia Patient With A Novel Progranulin Mutation

Neuronal Effects of Progranulin Deficiency Contribute to Frontotemporal Dementia Independent of Neuroinflammation

Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes

The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia

Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia

Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions in Vitro: A Cell Model of Frontotemporal Lobar Degeneration